In this study, we comprehensively explored ITGB1 expression in GC and its correlations with clinicopathological features, prognosis, the Wnt/β‐catenin signaling pathway, and tumor immune suppression and predicted the possibility of ITGB1 as a potentially important target for immunotherapy in our own cohort and public data sets. Here, ITGB1 is linked to gastric cancer.